CFO & Treasurer of Homology Medicines, Inc. (U.S.: Nasdaq:FIXX), Smith W Bradford, sells 2,182 shares worth $8,248
According to Homology Medicines, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 12 04:05 PM, company CFO & Treasurer, Smith W Bradford disclosed selling 2,182 shares at a cost of $3.78. At the time of this transaction (Jan 05), this trade was worth $8,248 in total. As of Jan 05, Smith W Bradford now owns 4,418 shares in total worth about $16,236.15.
For the last few recent trades made by Homology Medicines, Inc. (U.S.: Nasdaq:FIXX) CFO & Treasurer, Smith W Bradford, we have the following information:
- SEC Form 4 filing: Feb 08: Sold 13,500 shares at the rate of $14.25 per share. Total worth of this trade was $192,425. Total number of shares owned as of Feb 08 were 0
- SEC Form 4 filing: Feb 03: Sold 12,000 shares at the rate of $16.16 per share. Total worth of this trade was $193,866. Total number of shares owned as of Feb 03 were 0
- SEC Form 4 filing: Jan 02: Sold 6,000 shares at the rate of $20.50 per share. Total worth of this trade was $122,984. Total number of shares owned as of Jan 02 were 0
Posted by
George Daniels
on Thursday January 13 2022, 1:31 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
